Aclaris Therapeutics, Inc. (LON:0H8T)
London
· Delayed Price · Currency is GBP · Price in USD 1.468
-0.022 (-1.48%)
At close: Jul 3, 2025
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of 114.18 million as of July 3, 2025. Its market cap has increased by 79.91% in one year.
Market Cap
114.18M
Enterprise Value
-23.52M
Revenue
13.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.47
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has decreased from 140.05M to 114.18M, a decrease of -18.47%. That is a compound annual growth rate of -2.07%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.28B |
| GSK plc | 56.85B |
| Haleon | 33.95B |
| Smith & Nephew | 9.73B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 1.96B |
| Oxford Nanopore Technologies | 1.42B |